Oral antidiabetic for the metabolic control in gestational diabetes

Authors

  • Yoany Marín Tápanes Hospital Ginecoobstétrico “Mariana Grajales”, Santa Clara, Villa Clara, Cuba
  • Sandi Jiménez Puñales Hospital Ginecoobstétrico “Mariana Grajales”, Santa Clara, Villa Clara, Cuba

Keywords:

diabetes gestacional, hipoglicemiantes orales, control metabólico

Abstract

The search for alternative therapies to insulin for the treatment of gestational diabetes goes back to studies from the decade of 1970 and 1980. The oral hypoglycemic agents have emerged as an effective alternative for metabolic control of gestational diabetes; these drugs have historically been rejected by the medical community on the basis of studies with serious methodological flaws. Metformin is a useful and safe alternative for its control, to reduce costs and improve the margin of safety that involves the use of insulin. There is sufficient information that supports that glyburide is safe during pregnancy. Many of the fears for the use of oral hypoglycemic agents have been clarified today. Up to now it has not been reported in pregnant the use of other oral hypoglycemic agents and, therefore, they must not be used.

Downloads

Download data is not yet available.

Author Biographies

Yoany Marín Tápanes, Hospital Ginecoobstétrico “Mariana Grajales”, Santa Clara, Villa Clara, Cuba

Especialista de I Grado en Ginecología y Obstetricia. Máster en Atención Integral a la Mujer. Profesora Auxiliar de la Universidad de Ciencias Médicas de Villa Clara “Dr. Serafín Ruiz de Zárate Ruiz”.

Sandi Jiménez Puñales, Hospital Ginecoobstétrico “Mariana Grajales”, Santa Clara, Villa Clara, Cuba

Especialista de I Grado en Medicina General Integral. Especialista de I y II Grado en Ginecología y Obstetricia. Máster en Atención Integral a la Mujer. Profesor Auxiliar de la Universidad de Ciencias Médicas de Villa Clara “Dr. Serafín Ruiz de Zárate Ruiz”.

References

1. Gandhi P, Bustani R, Madhuvrata P, Farell T. Introduction of metformin for gestational diabetes mellitus in clinical practice: has it had an impact? Eur J Obstet Gynecol Reprod Biol [Internet]. 2012 [citado 15 Jul 2016]; 160(2):147-50. Disponible en: http://www.ncbi.nlm.nih.gov/pubmed/22137984

2. Diabetes y embarazo [Internet]. En: Aguila Setién S, Breto García A, Cabezas Cruz E, Delgado Calzado JJ, Santisteban Alba S. Obstetricia y perinatología diagnóstico y tratamiento. La Habana: Ciencias Médicas; 2012 [citado 26 Feb 2015]. p. 306-321. Disponible en: http://www.bvs.sld.cu/libros/obstetricia_perinatologia/cap50.pdf

3. Rivas A. Diabetes y embarazo: acuerdos y controversias sobre el diagnóstico y tratamiento. Salus [Internet]. 2015 [citado 15 Jul 2016];19(1):27-33. Disponible en: http://www.scielo.org.ve/pdf/s/v19n1/art06.pdf

4. San Martín-Herrasti JM, Alcázar-Álvarez LS, Serrano-Berrones MA, Tirado-Chávez J, Castro-Herrera GA. Metformina y diabetes gestacional. Rev Esp Méd Quir [Internet]. 2014 [citado 15 Jul 2016];19(3):347-355. Disponible en: http://www.redalyc.org/html/473/47332498014/

5. Gui J, Liu Q, Feng L. Metformin vs insulin in the management of gestational diabetes: a meta-analysis. PLoS One [Internet]. 2013 [citado 15 Jul 2016];8(5):e64585. Disponible en: http://www.ncbi.nlm.nih.gov/pubmed/23724063

6. Evelyn García-Herrera. Actualización sobre el uso de hipoglicemiantes orales para el tratamiento farmacológico en diabetes gestacional. Rev Méd Costa Rica Centroamerica [Internet]. 2014 [citado 15 Jul 2016]; LXXI (610): 225–229. Disponible en: http://www.binasss.sa.cr/revistas/rmcc/610/art09.pdf

7. González Montero C, Manso Platero FJ, López Alba AJ. Antidiabéticos orales y odontología. Av Odontoestomatol [Internet]. 2014 [citado 15 Jul 2016]; 30 (5): 271-281. Disponible en: http://scielo.isciii.es/pdf/odonto/v30n5/original4.pdf

8. Magon N, Seshiah V. Gestational diabetes mellitus: non-insulin management. Indian J Endocrinol Metab [Internet]. 2011 [citado 15 Jul 2016];15(4):284-293. Disponible en: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3193777/

9. Berggren EK, Boggess KA. Oral agents for the management of gestational diabetes. Clin Obstet Gynecol [Internet]. 2013 [citado 15 Jul 2016]; 56(4):827-836. Disponible en: http://www.ncbi.nlm.nih.gov/pubmed/24005130

10. Marques P, Carvalho MR, Pino L, Guerra S. Metformin safety in the management of gestational diabetes. Endocr Pract [Internet]. 2014 [citado 15 Jul 2016];20(10): 1022-31. Disponible en: http://www.ncbi.nlm.nih.gov/pubmed/24793923

11. Su DF, Wang XY. Metformin vs insulin in the management of gestational diabetes: a systematic review and meta-analysis. Diabetes Res Clin Pract [Internet]. 2014 [citado 15 Jul 2016];104(3):353-7. Disponible en: http://www.ncbi.nlm.nih.gov/pubmed/24768511

12. Tertti K, Ekblad U, Koskinen P, Vahlberg T, Rönnemaa T. Metformin vs. insulin in gestational diabetes. A randomized study characterizing metformin patients needing additional insulin. Diabetes Obes Metab [Internet]. 2013 [citado 15 Jul 2016];15(3):246-51. Disponible en: http://www.ncbi.nlm.nih.gov/pubmed/23020608

13. Holt RI, Lambert KD. The use of oral hypoglycaemic agents in pregnancy.Diabet Med [Internet]. 2014 [citado 15 Jul 2016];31(3):282-91. Disponible en: http://www.ncbi.nlm.nih.gov/pubmed/24528229

14. Lautatzis ME, Goulis DG, Vrontakis M. Efficacy and safety of metformin during pregnancy in women with gestational diabetes mellitus or polycystic ovary syndrome: a systematic review. Metabolism [Internet]. 2013 [citado 15 Jul 2016];62(11):1522-34. Disponible en: http://www.ncbi.nlm.nih.gov/pubmed/23886298

15. Spaulonci CP, Bernardes LS, Trindade TC, Zugaib M, Francisco RP. Randomized trial of metformin vs insulin in the management of gestational diabetes. Am J Obstet Gynecol [Internet]. 2013 [citado 15 Jul 2016]; 209(1):34.e1-7. Disponible en: http://www.ncbi.nlm.nih.gov/pubmed/23524173

16. Hickman MA, McBride R, Boggess KA, Strauss R. Metformin compared with insulin in the treatment of pregnant women with overt diabetes: a randomized controlled trial. Am J Perinatol [Internet]. 2013 [citado 15 Jul 2016];30(6):483-90. Disponible en: http://www.ncbi.nlm.nih.gov/pubmed/23096052

17. Salat D, Aguilera C. Tratamiento actual de la diabetes gestacional. Med Clin (Barc) [Internet]. 2015 [citado 15 Jul 2016];145(6):269–272. Disponible en: http://www.icf.uab.es/es/pdf/consulta/preres/preres55.pdf

18. Kremer CJ, Duff P. Glyburide for the treatment of gestational diabetes. Am J Obstet Gynecol [Internet]. 2004 [citado 15 Jul 2016]; 190(5):1438-9. Disponible en: http://www.ncbi.nlm.nih.gov/pubmed/15167862

19. Langer O. Oral anti-hyperglycemic agents for the management of gestational diabetes mellitus. Obstet Gynecol Clin North Am [Internet]. 2007 [citado 15 Jul 2016];34(2):255-274. Disponible: http://www.ncbi.nlm.nih.gov/pubmed/17572271

20. Poolsup N, Suksomboon N, Amin M. Efficacy and safety of oral antidiabetic drugs in comparison to insulin in treating gestational diabetes mellitus: a meta-analysis. PLoS One [Internet]. 2014 [citado 15 Jul 2016]; 9(10):e109985. Disponible en: http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0109985

21. Balsells M, García-Patterson A, Sola I, Roque M, Gich I, Corcoy R. Glibenclamide, metformin, and insulin for the treatment of gestational diabetes: a systematic review and meta-analysis. BMJ [Internet]. 2015 [citado 15 Jul 2016];350:h102. Disponible en: http://www.ncbi.nlm.nih.gov/pubmed/25609400

22. Lenhard MJ, Kinsley BT. Insulin therapy for the treatment of type 1 diabetes during pregnancy. J Matern Fetal Neonatal Med [Internet]. 2014 [citado 15 Jul 2016];27(12):1270–1275. Disponible en: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4133963/

23. Cassina M, Donà M, Di Gianantonio E, Litta P, Clementi M. First-trimester exposure to metformin and risk of birth defects: a systematic review and meta-analysis. Hum Reprod Update [Internet]. 2014 [citado 15 Jul 2016];20(5):656–69. Disponible en: http://www.ncbi.nlm.nih.gov/pubmed/24861556

24. Ijäs H, Vääräsmäki M, Saarela T, Keravuo R, Raudaskoski T. A follow-up of a randomised study of merformin and insulin in gestational diabetes mellitus: growth and developemt of the children at the age of 18 months. BJOG [Internet]. 2015 [citado 15 Jul 2016]; 122(7):994-1000. Disponible en: http://www.ncbi.nlm.nih.gov/pubmed/25039582

25. Silva JC, Fachin DR, Coral ML, Bertini AM. Perinatal impact of the use of metformin and glyburide for the treatment of gestational diabetes mellitus. J Perinat Med [Internet]. 2012 [citado 15 Jul 2016]; 40(3):225-8. Disponible en: http://www.ncbi.nlm.nih.gov/pubmed/22505499

26. Buckley BS, Harreiter J, Damm P, Corcoy R, Chico A, Simmons D, et al. Gestational diabetes mellitus in Europe: prevalence, current screening practice and barriers to screening. A review. Diabet Med [Internet]. 2012 [citado 15 Jul 2016];29(7):844–54. Disponible en: http://www.ncbi.nlm.nih.gov/pubmed/22150506

27. Hung TH, Hsieh TT. The effects of implementing the international association of diabetes and pregnancy study groups criteria for diagnosing gestational diabetes on maternal and neonatal outcomes. PLoS One [Internet]. 2015 [citado 15 Jul 2016]; 10:e0122261. Disponible en: http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0122261

28. Hernandez-Rivas E, Flores-Le Roux JA, Benaiges D, Sagarra E, Chillaron JJ, Paya A, et al. Gestational diabetes in a multiethnic population of Spain: clinical characteristics and perinatal outcomes. Diabetes Res Clin Pract [Internet]. 2013 [citado 15 Jul 2016];100(2):215–21. Disponible en: http://europepmc.org/abstract/med/23538268

29. Ovesen PG, Jensen DM, Damm P, Rasmussen S, Kesmodel US. Maternal and neonatal outcomes in pregnancies complicated by gestational diabetes. a nation-wide study. J Matern Fetal Neonatal Med [Internet]. 2015 [citado 15 Jul 2016];28(14):1720-4. Disponible en: http://www.ncbi.nlm.nih.gov/pubmed/25228278

30. Viana LV, Gross JL, Azevedo MJ. Dietary intervention in patients with gestational diabetes mellitus: a systematic review and meta-analysis of randomized clinical trials on maternal and newborn outcomes. Diabetes Care [Internet]. 2014 [citado 15 Jul 2016];37(12):3345–55. Disponible en: http://www.ncbi.nlm.nih.gov/pubmed/25414390

31. Camelo Castillo W, Boggess K, Stürmer T, Brookhart MA, Benjamin DK, Jonsson Funk M. Trends in glyburide compared with insulin use for gestational diabetes treatment in the United States, 2000-2011. Obstet Gynecol [Internet]. 2014 [citado 15 Jul 2016];123(6):1177–84. Disponible en: http://www.ncbi.nlm.nih.gov/pubmed/24807336

32. Cassina M, Donà M, Di Gianantonio E, Litta P, Clementi M. First-trimester exposure to metformin and risk of birth defects: a systematic review and meta-analysis. Hum Reprod Update [Internet]. 2014 [citado 15 Jul 2016];20(5):656-69. Disponible en: http://www.ncbi.nlm.nih.gov/pubmed/24861556

33. Mesdaghinia E, Samimi M, Homaei Z, Saberi F, Moosavi SG, et al. Comparison of newborn outcomes in women with gestational diabetes mellitus treated with metformin or insulin: a randomised blinded trial. Int J Prev Med [Internet]. 2013 [citado 15 Jul 2016];4(3):327-33. Disponible en: http://www.ncbi.nlm.nih.gov/pubmed/23626890

Downloads

Published

2016-10-03

How to Cite

1.
Marín Tápanes Y, Jiménez Puñales S. Oral antidiabetic for the metabolic control in gestational diabetes. Acta Méd Centro [Internet]. 2016 Oct. 3 [cited 2025 Jul. 3];10(4):81-90. Available from: https://revactamedicacentro.sld.cu/index.php/amc/article/view/769

Issue

Vol. 10 No. 4 (2016): October-December

Section

Review Articles

License

Authors who have publications with this journal agree to the following terms:

  1. Authors will retain their copyright and assign to the journal the right of first publication of their work, which will simultaneously be subject to a Creative Commons License / Attribution-Noncommercial 4.0 International (CC BY-NC 4.0) that allows third parties to share the work as long as its author and first publication in this journal are indicated.
  2. Authors may adopt other non-exclusive license agreements for distribution of the published version of the work (e.g., depositing it in an institutional repository or publishing it in a monographic volume) as long as the initial publication in this journal is indicated.
  3. Authors are allowed and encouraged to disseminate their work through the Internet (e.g., in institutional telematic archives or on their web page) before and during the submission process, which can produce interesting exchanges and increase citations of the published work. (See The effect of open access).